Company intelligence
Cytek Biosciences
Transcend The Conventional
About Cytek Biosciences
Cytek® Biosciences Inc. is a leading manufacturer and supplier of flow cytometry products and services. Cytek’s compact, affordable instruments and wide ranging support offerings are used by researchers and clinicians all over the world. Flow cytometry is a powerful analytical tool used for identifying and quantifying cellular characteristics on a cell-by-cell basis up to tens of thousands of cells per second. This technology is used in research and clinical studies with various biomedical and therapeutic applications such as investigating the role of the body’s immune system in fighting cancer, diagnosing leukemia and lymphoma, and detecting minimal residual disease in organ transplant patients. Flow cytometry has many advantages over traditional microscopy since it enables the analysis of a greater number of cells in a fraction of the time. At Cytek, we are focused on accelerating the adoption of flow cytometry for one simple reason: to fuel scientific discovery. We have leveraged our highly experienced, best-in-the-business team to bring forth an innovative new class of flow cytometry solutions. These solutions deliver deep biological insights at an affordable price, provide high-end capabilities, and bring simplified workflows to more researchers than ever before. As a company, we also seek to maintain high ethical standards and a culture that values honesty, integrity and transparency in all that we do. Company decisions are driven by what is right for scientific discovery and customer support. We are committed to our employees, to the environment in which we live and to the communities we serve worldwide. Cytek is headquartered in Fremont, California with branch offices and distribution channels across the globe. For more information, visit www.cytekbio.com.
Verified activity
Signals from Cytek Biosciences
6 published signals
Presence & Recognition
Cytek Biosciences is hosting the Cytek Industrial Partner Presentation titled Do We Really Need 40 Colors? Rethinking Spectral Cytometry For Routine Diagnostics And MRD Monitoring at ESCCA 2026 on Friday, September 11, 2026.
Reported by Cytek Biosciences
Research & Knowledge
Cytek Biosciences scientists collaborated with researchers at the Amsterdam University Medical Center to develop a spectral flow cytometry panel for deep immunophenotyping of NK cells in peripheral blood and human liver tissue.
Reported by Cytek Biosciences
Presence & Recognition
Cytek Biosciences is attending the annual meetings of the European Society for Clinical Cell Analysis, ESCCA, and the International Clinical Cytometry Society, ICCS 2026.
Reported by Cytek Biosciences
Research & Knowledge
Cytek Biosciences CEO Dr. Wenbin Jiang published a new Forbes article titled The Promise of Precision Medicine Is Becoming Practical exploring how genomic sequencing, AI, digital health, and advanced cell analysis are making personalized care more practical, scalable, and accessible.
Reported by Cytek Biosciences
Presence & Recognition
Cytek Biosciences CEO Maria Elena Gallina spoke on the future of medicine in Forbes.
Reported by Maria Elena Gallina
Research & Knowledge
Cytek Biosciences demonstrated high-dimensional spectral flow allowing scientists to establish long-term stability of fixed, frozen blood samples banked two and a half years.
Reported by Maria Elena Gallina